Download PDF
CC BY-NC-ND 4.0 · Indian Journal of Neurosurgery 2018; 07(01): 051-053
DOI: 10.1055/s-0036-1585426
Case Report
Thieme Medical and Scientific Publishers Private Ltd.

Paradoxical Tuberculomas Complicating Tuberculous Meningitis: About Two Cases

Cherkaoui Mandour
1   Department of Neurosurgery, Military Hospital Mohammed V, Rabat, Morocco
,
Jawad Laaguili
1   Department of Neurosurgery, Military Hospital Mohammed V, Rabat, Morocco
,
Miloudi Gazzaz
1   Department of Neurosurgery, Military Hospital Mohammed V, Rabat, Morocco
,
El Mostarchid Brahim
1   Department of Neurosurgery, Military Hospital Mohammed V, Rabat, Morocco
› Author Affiliations
Further Information

Publication History

Received: 14 January 2016

accepted after revision: 11 March 2016

Publication Date:
12 April 2017 (online)

   Permissions and Reprints

Abstract

Paradoxical tuberculomas in patients with tuberculous meningitis during antituberculous chemotherapy is an unusual phenomenon. This reaction is due to the immune response of the host to antituberculous drugs. It is commonly seen in the intensive phase of chemotherapy. We report the cases of two patients with tuberculous meningitis who had developed tuberculomas during adequate and appropriate antitubercular therapy. Tuberculous meningitis requires the regular clinical and radiological follow-up to detect paradoxical response.

Keywords

tuberculoma - paradoxical - meningitis
 

  • References

  • 1 Lees AJ, MacLeod AF, Marshall J. Cerebral tuberculomas developing during treatment of tuberculous meningitis. Lancet 1980; 1 8180 1208-1211
    PubMedGoogle Scholar
  • 2 Malik GM, Mubarik M, Basu JA, Kadla SA, Hussain T, Rashid S. Paradoxical expansion of cerebral tuberculomas during therapy for Pott's spine. J R Soc Med 1996; 89 (11) 643-644
    CrossrefPubMedGoogle Scholar
  • 3 Gupta M, Bajaj BK, Khwaja G. Paradoxical response in patients with CNS tuberculosis. J Assoc Physicians India 2003; 51: 257-260
    PubMedGoogle Scholar
  • 4 Shah I, Borse S. Paradoxical tuberculomas after completion of antituberculous treatment. Trop Med Health 2012; 40 (01) 15-17
    CrossrefPubMedGoogle Scholar
  • 5 Dubé MP, Holtom PD, Larsen RA. Tuberculous meningitis in patients with and without human immunodeficiency virus infection. Am J Med 1992; 93 (05) 520-524
    CrossrefPubMedGoogle Scholar
  • 6 Chambers ST, Hendrickse WA, Record C, Rudge P, Smith H. Paradoxical expansion of intracranial tuberculomas during chemotherapy. Lancet 1984; 2 8396 181-184
    PubMedGoogle Scholar
  • 7 Cheng V, Ho P, Lee R. et al. Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis 2002; 21 (11) 803-809
    CrossrefPubMedGoogle Scholar
  • 8 Zavascki AP, Dias AE, Cruz RP, de Oliveira RL, Duquia RP. Intracranial tuberculomas in an immunocompetent patient mimicking brain metastasis of unknown origin. Infection 2006; 34 (03) 181-182
    CrossrefPubMedGoogle Scholar
  • 9 Teoh R, Humphries MJ, O'Mahony G. Symptomatic intracranial tuberculoma developing during treatment of tuberculosis: a report of 10 patients and review of the literature. Q J Med 1987; 63 (241) 449-460
    PubMedGoogle Scholar
  • 10 Afghani B, Lieberman JM. Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review. Clin Infect Dis 1994; 19 (06) 1092-1099
    CrossrefPubMedGoogle Scholar